In studies with genetically engineered mice, Johns Hopkins Medicine researchers say they have identified a potentially new biological target involving Aplp1, a cell surface protein that drives the spread of Parkinson's disease-causing ...
Jun 17, 2024
0
69
A research team, led by Professors Tae-Hyuk Kwon and Duyoung Min from the Department of Chemistry at UNIST, has achieved a significant breakthrough in the battle against cancer through the utilization of reactive oxygen species ...
Jun 17, 2024
0
1
A new USC Leonard Davis School-led study highlights how transposons—commonly called "jumping genes" because of their ability to move to different parts of the genome—are associated with age-related disease and decline, ...
Jun 17, 2024
0
5
Treatment outcomes for breast cancer have become better over the years, but a proportion of breast cancers still recur even after long periods without signs of cancer remaining dormant in the body. Finnish cancer researchers ...
Jun 17, 2024
0
39
Researchers at Brigham and Women's Hospital have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system's ability to fight cancer.
Jun 14, 2024
0
70
A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy—a cell-based cancer treatment that exploded on the scene in 2017 as a treatment for intractable ...
Jun 12, 2024
0
14
Metabolic syndrome (MetS) is a health condition characterized by a group of risk factors: high blood pressure, high blood sugar, unhealthy cholesterol levels, and abdominal fat. These factors increase the risk of heart disease, ...
Jun 11, 2024
0
17
By studying mutations in yeast and human cells, Johns Hopkins Medicine scientists say they have found that biochemical bonds between fats and proteins in the mitochondrion, the cell's powerhouse, play a crucial role in how ...
Jun 7, 2024
0
0
In the relentless fight against cancer, a new technology promises to shed light on how we track and understand the spread of this disease within the body. A research team from Northeastern University and Dartmouth College ...
Jun 7, 2024
0
1
The role that Epstein-Barr virus (EBV) plays in the development of multiple sclerosis (MS) may be caused by a higher level of cross-reactivity, where the body's immune system binds to the wrong target, than previously thought.
Jun 6, 2024
0
63
